top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anti-cancer Drugs : Nature, Synthesis and Cell / / edited by Jasna Bankovic
Anti-cancer Drugs : Nature, Synthesis and Cell / / edited by Jasna Bankovic
Pubbl/distr/stampa Rijeka, Croatia : , : IntechOpen, , 2016
Descrizione fisica 1 online resource (196 pages) : illustrations
Disciplina 616.9
Soggetto topico Liver - Cancer - Treatment
ISBN 953-51-7328-6
953-51-2814-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Anti-cancer drugs
Anti-cancer Drugs - Nature, Synthesis and Cell
Record Nr. UNINA-9910169207203321
Rijeka, Croatia : , : IntechOpen, , 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Clinical dilemmas in primary liver cancer [[electronic resource] /] / edited by Roger Williams, Simon D. Taylor-Robinson
Clinical dilemmas in primary liver cancer [[electronic resource] /] / edited by Roger Williams, Simon D. Taylor-Robinson
Pubbl/distr/stampa Chichester, West Sussex, : John Wiley & Sons, 2012
Descrizione fisica x, 218 p., [7] p. of plates : ill. (some col.), col. map
Disciplina 616.99/436
Altri autori (Persone) WilliamsRoger <1931->
Taylor-RobinsonSimon D
Soggetto topico Liver - Cancer
Liver - Cancer - Diagnosis
Liver - Cancer - Treatment
ISBN 1-119-96220-X
1-119-96217-X
9786613333148
1-283-33314-7
1-119-96218-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto pt. 1. Learning from a worldwide perspective -- pt. 2. Influence of tumor characteristics -- pt. 3. Complexities of patient assessment and scoring systems -- pt. 4. Choice of radiological diagnostic technique -- pt. 5. Can treatment be tailored to the patient? -- pt. 6. What does the future hold?.
Record Nr. UNINA-9910208840903321
Chichester, West Sussex, : John Wiley & Sons, 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Clinical dilemmas in primary liver cancer / / edited by Roger Williams, Simon D. Taylor-Robinson
Clinical dilemmas in primary liver cancer / / edited by Roger Williams, Simon D. Taylor-Robinson
Edizione [1st ed.]
Pubbl/distr/stampa Chichester, West Sussex, : John Wiley & Sons, 2012
Descrizione fisica x, 218 p., [7] p. of plates : ill. (some col.), col. map
Disciplina 616.99/436
Altri autori (Persone) WilliamsRoger <1931->
Taylor-RobinsonSimon D
Soggetto topico Liver - Cancer
Liver - Cancer - Diagnosis
Liver - Cancer - Treatment
ISBN 1-119-96220-X
1-119-96217-X
9786613333148
1-283-33314-7
1-119-96218-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto pt. 1. Learning from a worldwide perspective -- pt. 2. Influence of tumor characteristics -- pt. 3. Complexities of patient assessment and scoring systems -- pt. 4. Choice of radiological diagnostic technique -- pt. 5. Can treatment be tailored to the patient? -- pt. 6. What does the future hold?.
Record Nr. UNINA-9910818185103321
Chichester, West Sussex, : John Wiley & Sons, 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Hepatocellular Carcinoma : Challenges and Opportunities of a Multidisciplinary Approach / / edited by Georgios Tsoulfas
Hepatocellular Carcinoma : Challenges and Opportunities of a Multidisciplinary Approach / / edited by Georgios Tsoulfas
Pubbl/distr/stampa London : , : IntechOpen, , 2022
Descrizione fisica 1 online resource (202 pages) : illustrations
Disciplina 616.9
Soggetto topico Liver - Cancer - Treatment
Liver - Cancer - Diagnosis
ISBN 1-83969-111-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Hepatocellular Carcinoma
Record Nr. UNINA-9910586642703321
London : , : IntechOpen, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunotherapy in Hepatocellular Carcinoma / / edited by Naoshi Nishida and Masatoshi Kudo
Immunotherapy in Hepatocellular Carcinoma / / edited by Naoshi Nishida and Masatoshi Kudo
Pubbl/distr/stampa [Place of publication not identified] : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023
Descrizione fisica 1 online resource (274 pages)
Disciplina 616.99436
Soggetto topico Liver - Cancer - Treatment
Liver - Cancer
ISBN 3-0365-6690-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910719781303321
[Place of publication not identified] : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.]
Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.]
Edizione [3rd ed.]
Pubbl/distr/stampa Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010
Descrizione fisica 1 online resource (576 p.)
Disciplina 616.99436
Altri autori (Persone) ClavienPierre-Alain
Abou-AlfaGhassan (MSKCC.)
CassilethBarrie R (MSKCC.)
DaiMenghua (MSKCC.)
FongYuman (MSKCC.)
GonzalezLorena (MSKCC.)
GubiliJyothirmai (MSKCC.)
KemenyNancy (MSKCC.)
Soggetto topico Liver - Cancer - Treatment
Oncology
Soggetto genere / forma Electronic books.
ISBN 1-282-38511-9
9786612385117
1-4443-1705-9
1-4443-1706-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Malignant Liver Tumors: Current and Emerging Therapies, THIRD EDITION; Contents; Contributors; Preface; Acknowledgments; Abbreviations; Section 1: Introduction; Section 2: Epidemiology and Diagnosis; Section 3: Systemic and Regional Therapies; Section 4: Resection, Ablation or Transplantation for Liver Tumors; Section 5: Guidelines for Liver Tumor Treatment; Section 6: Emerging Therapies; Section 7: Special Tumors, Population, and Special Considerations; Index
Record Nr. UNINA-9910139970803321
Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.]
Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.]
Edizione [3rd ed.]
Pubbl/distr/stampa Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010
Descrizione fisica 1 online resource (576 p.)
Disciplina 616.99436
Altri autori (Persone) ClavienPierre-Alain
Abou-AlfaGhassan (MSKCC.)
CassilethBarrie R (MSKCC.)
DaiMenghua (MSKCC.)
FongYuman (MSKCC.)
GonzalezLorena (MSKCC.)
GubiliJyothirmai (MSKCC.)
KemenyNancy (MSKCC.)
Soggetto topico Liver - Cancer - Treatment
Oncology
ISBN 1-282-38511-9
9786612385117
1-4443-1705-9
1-4443-1706-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Malignant Liver Tumors: Current and Emerging Therapies, THIRD EDITION; Contents; Contributors; Preface; Acknowledgments; Abbreviations; Section 1: Introduction; Section 2: Epidemiology and Diagnosis; Section 3: Systemic and Regional Therapies; Section 4: Resection, Ablation or Transplantation for Liver Tumors; Section 5: Guidelines for Liver Tumor Treatment; Section 6: Emerging Therapies; Section 7: Special Tumors, Population, and Special Considerations; Index
Record Nr. UNISA-996214693803316
Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.]
Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.]
Edizione [3rd ed.]
Pubbl/distr/stampa Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010
Descrizione fisica 1 online resource (576 p.)
Disciplina 616.99436
Altri autori (Persone) ClavienPierre-Alain
Abou-AlfaGhassan (MSKCC.)
CassilethBarrie R (MSKCC.)
DaiMenghua (MSKCC.)
FongYuman (MSKCC.)
GonzalezLorena (MSKCC.)
GubiliJyothirmai (MSKCC.)
KemenyNancy (MSKCC.)
Soggetto topico Liver - Cancer - Treatment
Oncology
ISBN 1-282-38511-9
9786612385117
1-4443-1705-9
1-4443-1706-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Malignant Liver Tumors: Current and Emerging Therapies, THIRD EDITION; Contents; Contributors; Preface; Acknowledgments; Abbreviations; Section 1: Introduction; Section 2: Epidemiology and Diagnosis; Section 3: Systemic and Regional Therapies; Section 4: Resection, Ablation or Transplantation for Liver Tumors; Section 5: Guidelines for Liver Tumor Treatment; Section 6: Emerging Therapies; Section 7: Special Tumors, Population, and Special Considerations; Index
Record Nr. UNINA-9910829990303321
Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Autore Mukherjee Biswajit
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers, , 2022
Descrizione fisica 1 online resource (557 pages)
Disciplina 616.99436
Soggetto topico Liver - Cancer - Treatment
Soggetto non controllato Oncology
Medical
ISBN 981-5039-74-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Hepatocellular Carcinoma: Diagnosis, Molecular Pathogenesis, Biomarkers, and Conventional Therapy -- Biswajit Mukherjee*, 1, Manasadeepa Rajagopalan2, Samrat Chakraborty1, Prasanta Ghosh1, Manisheeta Ray1, Ramkrishna Sen1 and Iman Ehsan1 -- INTRODUCTION -- CANCER AND ITS TYPES -- Primary Liver Cancer -- Hepatocellular Carcinoma (HCC) -- Intrahepatic Cholangiocarcinoma (Bile Duct Cancer) -- Angiosarcoma and Hemangiosarcoma -- Hepatoblastoma -- Secondary Liver Cancer Surgical Resection in Advanced HCC -- Anatomical Resection -- Laparoscopic Resection of The Liver -- Surgical Resection of Re-Occurring HCC -- Liver Transplantation -- Ablation -- Palliative Treatment -- Embolizing Therapies for HCC -- Transarterial Chemoembolization (TACE) -- Radiotherapy -- Systemic Therapies of HCC -- First-line Therapy -- Second-line Therapy -- Multi-Target Tyrosine Kinase Inhibitors -- Immune Checkpoint Inhibitor -- FUTURE PERSPECTIVES -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES DETAIL DESCRIPTION OF HCC -- Staging System in HCC -- Risk Factors for HCC -- Pathophysiology of HCC -- Molecular and Cellular Features of the Tumor Microenvironment -- Importance of Cancer Stem Cells in HCC -- Inflammation and HCC -- Oxidative Stress in HCC -- Epithelial-Mesenchymal Transition (EMT) -- Hypoxia and HCC -- Impairment of Cell Cycle in HCC -- Loss of Senescence Control -- Apoptosis and HCC -- Cellular Signalling Pathways in HCC -- EGF/TGF-a pathway -- Insulin Growth Factor (IGF) Pathway -- HGF/c-Met Pathway -- Signaling Pathways Involved in Neovascularization in HCC -- MAPK Pathways PI3K/Akt/mTOR Pathway -- Signaling Pathways Related to Cell Differentiation and Development -- Wnt-ß Catenin Pathway -- Hedgehog (Hh) Signaling -- Notch Pathway -- Hippo Pathway -- Target Receptor(s) and Biomarker Proteins in HCC -- Asialoglycoprotein Receptor -- Glypican-3 (GPC3) -- Transferrin Receptor (TfR) -- Heat Shock Protein 70 (HSP70) -- Tumor-Associated Glycoprotein-72 (TAG-72) -- Golgi Protein73 (GP73) -- Ki-67 Antigen -- Somatostatin Receptor (SSTR) -- Homodimeric Glycoprotein (AF-20) -- Osteopontin (OPN) -- Des-?-Carboxyprothrombin -- a-Fetoprotein (AFP) Squamous Cell Carcinoma Antigen (SCCA) -- Hepatocyte Paraffin 1 (HepPar1) -- APO-J -- DKK-1 (Dickkopf-p1) -- Human Carbonyl Reductase 2 (HCR2) -- Midkine -- Nerve Growth Factor (NGF) -- Vascular Endothelial Growth Factor (VEGF) -- Transforming Growth Factor-ß (TGF-ß) -- Epidermal Growth Factor (EGFR) -- Hepatocyte Growth Factor (HGF) -- a-1-Fucosidase -- Annexin A2 -- Micro RNA -- Circular RNAs -- Cancer Stem Markers -- CD44 -- CD133 -- CD90 -- Epithelial Cell Adhesion Molecule (EpCAM) -- SURVEILLANCE AND HCC -- TREATMENT STRATEGIES -- Curative Treatments -- Surgical Resection.
Record Nr. UNINA-9910795155203321
Mukherjee Biswajit  
Singapore : , : Bentham Science Publishers, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Autore Mukherjee Biswajit
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers, , 2022
Descrizione fisica 1 online resource (557 pages)
Disciplina 616.99436
Soggetto topico Liver - Cancer - Treatment
Soggetto non controllato Oncology
Medical
ISBN 981-5039-74-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Hepatocellular Carcinoma: Diagnosis, Molecular Pathogenesis, Biomarkers, and Conventional Therapy -- Biswajit Mukherjee*, 1, Manasadeepa Rajagopalan2, Samrat Chakraborty1, Prasanta Ghosh1, Manisheeta Ray1, Ramkrishna Sen1 and Iman Ehsan1 -- INTRODUCTION -- CANCER AND ITS TYPES -- Primary Liver Cancer -- Hepatocellular Carcinoma (HCC) -- Intrahepatic Cholangiocarcinoma (Bile Duct Cancer) -- Angiosarcoma and Hemangiosarcoma -- Hepatoblastoma -- Secondary Liver Cancer Surgical Resection in Advanced HCC -- Anatomical Resection -- Laparoscopic Resection of The Liver -- Surgical Resection of Re-Occurring HCC -- Liver Transplantation -- Ablation -- Palliative Treatment -- Embolizing Therapies for HCC -- Transarterial Chemoembolization (TACE) -- Radiotherapy -- Systemic Therapies of HCC -- First-line Therapy -- Second-line Therapy -- Multi-Target Tyrosine Kinase Inhibitors -- Immune Checkpoint Inhibitor -- FUTURE PERSPECTIVES -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES DETAIL DESCRIPTION OF HCC -- Staging System in HCC -- Risk Factors for HCC -- Pathophysiology of HCC -- Molecular and Cellular Features of the Tumor Microenvironment -- Importance of Cancer Stem Cells in HCC -- Inflammation and HCC -- Oxidative Stress in HCC -- Epithelial-Mesenchymal Transition (EMT) -- Hypoxia and HCC -- Impairment of Cell Cycle in HCC -- Loss of Senescence Control -- Apoptosis and HCC -- Cellular Signalling Pathways in HCC -- EGF/TGF-a pathway -- Insulin Growth Factor (IGF) Pathway -- HGF/c-Met Pathway -- Signaling Pathways Involved in Neovascularization in HCC -- MAPK Pathways PI3K/Akt/mTOR Pathway -- Signaling Pathways Related to Cell Differentiation and Development -- Wnt-ß Catenin Pathway -- Hedgehog (Hh) Signaling -- Notch Pathway -- Hippo Pathway -- Target Receptor(s) and Biomarker Proteins in HCC -- Asialoglycoprotein Receptor -- Glypican-3 (GPC3) -- Transferrin Receptor (TfR) -- Heat Shock Protein 70 (HSP70) -- Tumor-Associated Glycoprotein-72 (TAG-72) -- Golgi Protein73 (GP73) -- Ki-67 Antigen -- Somatostatin Receptor (SSTR) -- Homodimeric Glycoprotein (AF-20) -- Osteopontin (OPN) -- Des-?-Carboxyprothrombin -- a-Fetoprotein (AFP) Squamous Cell Carcinoma Antigen (SCCA) -- Hepatocyte Paraffin 1 (HepPar1) -- APO-J -- DKK-1 (Dickkopf-p1) -- Human Carbonyl Reductase 2 (HCR2) -- Midkine -- Nerve Growth Factor (NGF) -- Vascular Endothelial Growth Factor (VEGF) -- Transforming Growth Factor-ß (TGF-ß) -- Epidermal Growth Factor (EGFR) -- Hepatocyte Growth Factor (HGF) -- a-1-Fucosidase -- Annexin A2 -- Micro RNA -- Circular RNAs -- Cancer Stem Markers -- CD44 -- CD133 -- CD90 -- Epithelial Cell Adhesion Molecule (EpCAM) -- SURVEILLANCE AND HCC -- TREATMENT STRATEGIES -- Curative Treatments -- Surgical Resection.
Record Nr. UNINA-9910810523403321
Mukherjee Biswajit  
Singapore : , : Bentham Science Publishers, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui